01 Increasing Shift Toward Algae-Derived Alternatives to Fish OilThe algae omega-3 ingredients market is shifting toward marine-algae-derived DHA and EPA as food, nutrition, and supplement manufacturers seek alternatives to conventional fish-oil sources. Algal oils can provide omega-3 fatty acids through controlled cultivation while supporting vegetarian and vegan formulations and reducing dependence on marine-derived inputs. Improvements in cultivation and extraction technologies are further supporting the use of algae oils across nutraceuticals, functional foods, aquafeed, and other applications.In June 2025, a peer-reviewed review published in Bioresource Technology Reports identified algal oil as a sustainable source of DHA and EPA and highlighted its integration into nutraceuticals, functional foods, and aquafeed applications.
02 Expansion of High-Purity Algal DHA Across Food and Nutrition ApplicationsThe market is increasingly moving toward concentrated algal oils that can provide standardized DHA levels for specific food and nutrition applications. Regulatory acceptance is enabling suppliers to introduce different algal strains and oil concentrations into established food categories, including infant nutrition. This is broadening the commercial use of algae-derived omega-3 ingredients beyond dietary supplements.In June 2025, the U.S. FDA issued a “no questions” response for a GRAS notice covering algal oil containing at least 40% DHA from Aurantiochytrium limacinum, including intended use in foods and infant formula.
01 Growing Demand for Sustainable Omega-3 Sources Supports Algae Ingredient AdoptionIncreasing attention to marine-resource sustainability is encouraging manufacturers to consider algae as a direct source of DHA and EPA rather than relying entirely on fish-derived oils. Microalgae can be cultivated under controlled conditions and provide a source of omega-3 fatty acids suitable for plant-based formulations. This sustainability positioning is supporting adoption among food, supplement, and nutrition companies seeking alternatives to conventional marine ingredients.
01 Higher Production Complexity Can Increase the Cost of Algal Omega-3 IngredientsAlgal omega-3 production requires controlled cultivation, biomass recovery, oil extraction, purification, and concentration processes. These specialized operations can increase production costs compared with established marine-oil supply chains, particularly when manufacturers require highly concentrated or application-specific DHA and EPA ingredients. Cost differences can therefore restrict adoption in price-sensitive food and supplement formulations.
01 Expansion of Algal DHA in Infant Nutrition Creates New Ingredient OpportunitiesInfant nutrition provides an important opportunity because DHA is incorporated into infant-formula formulations and requires controlled ingredient specifications. Regulatory acceptance of additional algal-oil sources allows ingredient suppliers to expand the available supply base and develop oils with standardized DHA concentrations. This can support broader use of algae-derived DHA in infant formula and specialized nutrition products.
01 Scaling Algal Production While Maintaining Consistent Ingredient Quality Challenges SuppliersAlgae-based omega-3 producers must maintain consistent fatty-acid profiles, purity, oxidation stability, and production yields while scaling biological cultivation systems. Differences in algal strains and processing conditions can affect the composition and quality of the resulting oil. Suppliers therefore need to combine strain selection, controlled cultivation, efficient extraction, and quality management to deliver standardized ingredients at commercially viable volumes.
June 2026 Corbion expanded its algae-based omega-3 ingredient portfolio by launching advanced sustainable DHA solutions designed for infant nutrition, dietary supplements, and functional food applications. The new ingredients focus on improving nutritional value, supporting clean-label product development, and meeting growing consumer demand for plant-based alternatives to traditional marine omega-3 sources.
April 2026 DSM-Firmenich expanded its nutrition and health ingredient portfolio by introducing enhanced algae-derived omega-3 solutions featuring improved purity, stability, and sustainability benefits for food, beverage, and supplement manufacturers.
January 2026 Veramaris expanded its algae oil production capabilities by strengthening its sustainable omega-3 ingredient offerings for aquaculture feed, pet nutrition, and human health applications while reducing dependence on fish-based omega-3 sources.
October 2025 Lonza expanded its nutritional ingredient portfolio by introducing advanced algae-based omega-3 formulations designed to support dietary supplement brands seeking sustainable and traceable ingredient solutions.